Benefits
Targeted enzymes vs. broad-spectrum blends — choosing the right approach
Multi-enzyme blends are most appropriate when an individual experiences general post-meal discomfort with mixed meals or has documented broad-spectrum digestive insufficiency. However, for specific issues, individual targeted enzymes are often more effective and less expensive: lactose intolerance → Lactase alone (Lactaid); legume gas → Alpha-Galactosidase alone (Beano); FODMAP sensitivity → Fructan Hydrolase (FODZYME); pancreatic insufficiency → Prescription Pancrelipase (Creon, Zenpep); low stomach acid → Betaine HCl. Broad-spectrum blends like DigeZyme® shine when symptoms are non-specific or when consuming highly variable meals. Always match the enzyme to the documented or suspected deficiency or trigger food rather than assuming 'more enzymes is better'.
Comprehensive macronutrient digestion support
DigeZyme® provides the full enzymatic toolkit to digest all major macronutrients: amylase for starches and complex carbohydrates, protease for dietary proteins, lipase for fats and oils, cellulase for plant fiber cell walls, and lactase for milk sugar — supporting complete nutrient breakdown and absorption from varied diets.
Reduced digestive discomfort and bloating
A small randomized trial of DigeZyme (40 adults with functional dyspepsia, 50 mg three times daily for 60 days) improved overall dyspepsia symptom scores versus placebo, and a separate trial of a different fungal multi-enzyme blend (120 adults) improved dyspepsia and sleep scores. Both trials measured symptom questionnaires rather than bloating or flatulence individually, so relief of those specific symptoms is plausible but was not measured directly. By ensuring complete macronutrient digestion in the small intestine, less undigested substrate reaches the colon where fermentation causes discomfort.
Protein digestion and exercise recovery: manufacturer-reported only
The manufacturer (Sabinsa) reports a small study of DigeZyme plus whey protein in trained adults showing reduced muscle soreness and creatine kinase versus whey alone. That study does not appear to have a peer-reviewed, PubMed-indexed publication, so this benefit rests on industry-reported data that has not been independently verified. Protease activity could in principle aid protein digestion, but a measured effect on muscle recovery is not established in published human trials.
Lactose intolerance support
The lactase enzyme in DigeZyme® hydrolyzes lactose into glucose and galactose before it reaches the colon, preventing the fermentation-driven gas, bloating, and diarrhea experienced by lactose-intolerant individuals consuming dairy products. This describes the general lactase mechanism; neither cited DigeZyme trial measured lactose-intolerance outcomes, so this reflects how lactase works rather than a tested effect of the blend.
Nutrient bioavailability enhancement
Complete enzymatic breakdown of food matrices releases bound micronutrients (vitamins, minerals) from food structures, which could in principle improve their bioavailability. This nutrient-releasing effect is a proposed mechanism and has not been measured for the blend in human trials.
Mechanism of action
pH-stable enzyme activity across GI tract
DigeZyme® enzymes are produced from Aspergillus and other fungal sources specifically for their stability across the wide pH range of the GI tract (pH 2–8). Unlike pancreatic enzymes that function optimally at pH 7–8, DigeZyme® maintains activity from the acidic stomach through the alkaline small intestine, providing digestion support throughout the entire GI transit.
Substrate-specific hydrolytic activity
Each enzyme component specifically targets its substrate: alpha-amylase cleaves alpha-1,4-glycosidic bonds in starch, protease cleaves peptide bonds, lipase hydrolyzes ester bonds in triglycerides, cellulase cleaves beta-1,4-glycosidic bonds in cellulose, and lactase cleaves beta-galactosidic bonds in lactose. This substrate specificity ensures comprehensive digestion without interfering with normal GI physiology.
Pre-colonic digestion completion
By completing macronutrient hydrolysis in the small intestine, DigeZyme® reduces the amount of undigested carbohydrate, protein, and fat reaching the colon. Less colonic fermentation substrate means reduced gas production, shorter GI transit time, and reduced exposure of the colonic epithelium to potentially irritating fermentation byproducts.
Clinical trials
Randomized, double-blind, placebo-controlled trial of DigeZyme® combined with whey protein vs whey protein alone in 20 trained adults examining recovery markers (DOMS, creatine kinase) post-resistance training. This specific DigeZyme + whey trial is documented by the manufacturer (Sabinsa) and may not have a full PubMed-indexed publication.
20 trained adults. Acute/short-term recovery study.
Sabinsa reports DigeZyme® + whey protein significantly reduced DOMS, CK levels, and recovery time vs whey alone. Critical caveat: industry-funded; not extensively peer-reviewed. Mechanism proposed via enhanced protein digestion/absorption. Independent replication needed before strong confidence.
Randomized, double-blind, placebo-controlled trial of DigeZyme (50 mg three times daily) in 40 adults with functional dyspepsia over 60 days (Majeed et al., 2018, J Med Food; funded by Sabinsa, the manufacturer).
Adults with functional dyspepsia.
DigeZyme improved validated dyspepsia symptom scores (SF-LDQ, NDI-SF, VAS) versus placebo. The trial measured questionnaire-based symptom severity rather than bloating or flatulence individually, and it was small (n=40) and industry-funded, with no independent replication.